ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

MCRB Seres Therapeutics Inc

1.15
0.04 (3.60%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Seres Therapeutics Inc MCRB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.04 3.60% 1.15 08:56:13
始値 安値 高値 終値 前日終値
1.11 1.08 1.19 1.16 1.11
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0920:00BWSeres Therapeutics Announces Completion of Patient..
2024/3/2820:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
2024/3/1920:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
2024/3/0600:18EDGAR2Form DEF 14A - Other definitive proxy statements
2024/3/0600:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0521:05EDGAR2Form 8-K - Current report
2024/3/0521:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/3/0520:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
2024/2/2821:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
2024/2/2721:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
2024/2/2621:06EDGAR2Form 8-K - Current report
2024/2/2621:00BWSeres Therapeutics Announces the Appointment of Marella..
2024/2/2406:05EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/1711:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1711:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1711:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1711:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1711:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3106:01EDGAR2Form 8-K - Current report
2024/1/1721:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
2024/1/1021:00EDGAR2Form 8-K - Current report
2024/1/0922:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
2024/1/0921:05EDGAR2Form 8-K - Current report
2024/1/0921:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
2024/1/0506:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
2024/1/0306:05EDGAR2Form 8-K - Current report
2023/12/0809:46BWSeres Therapeutics Announces Presentation of Preliminary..
2023/11/2823:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
2023/11/2809:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
2023/11/2120:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
2023/11/0223:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0220:05EDGAR2Form 8-K - Current report
2023/11/0220:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0123:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
2023/11/0110:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0110:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0110:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0110:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0110:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0110:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3106:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
2023/10/1220:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
2023/10/0620:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
2023/10/0420:00EDGAR2Form 8-K - Current report
2023/9/1119:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
2023/9/0820:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
2023/9/0723:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
2023/8/2922:00PRNUSInvaio achieves first registration for citrus greening..
2023/8/1613:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/0905:07EDGAR2Form S-3 - Registration statement under Securities Act of..

最近閲覧した銘柄

Delayed Upgrade Clock